<code id='F1FDA1642A'></code><style id='F1FDA1642A'></style>

<acronym id='F1FDA1642A'></acronym>

<center id='F1FDA1642A'><center id='F1FDA1642A'><tfoot id='F1FDA1642A'></tfoot></center><abbr id='F1FDA1642A'><dir id='F1FDA1642A'><tfoot id='F1FDA1642A'></tfoot><noframes id='F1FDA1642A'>

<optgroup id='F1FDA1642A'><strike id='F1FDA1642A'><sup id='F1FDA1642A'></sup></strike><code id='F1FDA1642A'></code></optgroup>

<b id='F1FDA1642A'><label id='F1FDA1642A'><select id='F1FDA1642A'><dt id='F1FDA1642A'><span id='F1FDA1642A'></span></dt></select></label></b><u id='F1FDA1642A'></u>

~~<i id='F1FDA1642A'><strike id='F1FDA1642A'><tt id='F1FDA1642A'><pre id='F1FDA1642A'></pre></tt></strike></i>~~

Home» comprehensive» comprehensive

comprehensive

comprehensive

author：focus 2025-09-28 13:32:41 Page View：32287

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

advertisement

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Flash flooding emergencies prompt evacuations in Kentucky, Tennessee
Next article： Virginia high school admissions case could be legal follow

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Change Healthcare cyberattack prompts Medicare loan program

Change Healthcare cyberattack prompts Medicare loan program

AdobeMedicareannouncedonSaturdaythatitwillmakeadvancepaymentsavailabletophysiciangroups,hospitals,an

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Does Medicare's free annual wellness visit do any good?

JoeRaedle/GettyImagesTheannualcheckupisanalmostdistinctlyAmericanritual.It’sthesinglemostcommonreaso

read more